I agree that this site is using cookies. You can find further informations
here
.
X
Login
Merkliste (
0
)
Home
About us
Home About us
Our history
Profile
Press & public relations
Friends
The library in figures
Exhibitions
Projects
Training, internships, careers
Films
Services & Information
Home Services & Information
Lending and interlibrary loans
Returns and renewals
Training and library tours
My Account
Library cards
New to the library?
Download Information
Opening hours
Learning spaces
PC, WLAN, copy, scan and print
Catalogs and collections
Home Catalogs and Collections
Rare books and manuscripts
Digital collections
Subject Areas
Our sites
Home Our sites
Central Library
Law Library (Juridicum)
BB Business and Economics (BB11)
BB Physics and Electrical Engineering
TB Engineering and Social Sciences
TB Economics and Nautical Sciences
TB Music
TB Art & Design
TB Bremerhaven
Contact the library
Home Contact the library
Staff Directory
Open access & publishing
Home Open access & publishing
Reference management: Citavi & RefWorks
Publishing documents
Open Access in Bremen
zur Desktop-Version
Toggle navigation
Merkliste
1 Ergebnisse
1
Phase II Study to Evaluate the Efficacy and Safety of Rilot..:
Affronti, Mary Lou
;
Jackman, Jennifer Gamboa
;
McSherry, Frances
...
The Oncologist. 23 (2018) 8 - p. 889-e98 , 2018
Link:
https://doi.org/10.1634/theoncologist.2018-0149
RT Journal T1
Phase II Study to Evaluate the Efficacy and Safety of Rilotumumab and Bevacizumab in Subjects with Recurrent Malignant Glioma
UL https://suche.suub.uni-bremen.de/peid=cr-10.1634_theoncologist.2018-0149&Exemplar=1&LAN=DE A1 Affronti, Mary Lou A1 Jackman, Jennifer Gamboa A1 McSherry, Frances A1 Herndon II, James E. A1 Massey Jr., Elwood C. A1 Lipp, Eric A1 Desjardins, Annick A1 Friedman, Henry S. A1 Vlahovic, Gordana A1 Vredenburgh, James A1 Peters, Katherine B. PB Oxford University Press (OUP) YR 2018 SN 1083-7159 SN 1549-490X JF The Oncologist VO 23 IS 8 SP 889 OP e98 LK http://dx.doi.org/https://doi.org/10.1634/theoncologist.2018-0149 DO https://doi.org/10.1634/theoncologist.2018-0149 SF ELIB - SuUB Bremen
Export
RefWorks (nur Desktop-Version!)
Flow
(Zuerst in
Flow
einloggen, dann importieren)